Application Nr Approved Date Route Status External Links
NDA204441 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Jynarque Is Indicated To Slow Kidney Function Decline In Adults At Risk Of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (Adpkd). Jynarque Is A Selective Vasopressin V 2 -Receptor Antagonist Indicated To Slow Kidney Function Decline In Adults At Risk Of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (Adpkd) ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tolvaptan TOLVAPTAN ZINC1490477

Comments